Literature DB >> 23042826

A bias-corrected net reclassification improvement for clinical subgroups.

Nina P Paynter1, Nancy R Cook1.   

Abstract

BACKGROUND: Comparing prediction models using reclassification within subgroups at intermediate risk is often of clinical interest.
OBJECTIVE: To demonstrate a method for obtaining an unbiased estimate for the Net Reclassification Improvement (NRI) evaluated only on a subset, the clinical NRI. STUDY
DESIGN: and Setting. We derived the expected value of the clinical NRI under the null hypothesis using the same principles as the overall NRI. We then conducted a simulation study based on a logistic model with a known predictor and a potential predictor, varying the effects of the known and potential predictors to test the performance of our bias-corrected clinical NRI measure. Finally, data from the Women's Health Study, a prospective cohort of 24 171 female health professionals, were used as an example of the proposed method.
RESULTS: Our bias-corrected estimate is shown to have a mean of zero in the null case under a range of simulated parameters and, unlike the naïve estimate, to be unbiased. We also provide 2 methods for obtaining a variance estimate, both with reasonable type 1 errors.
CONCLUSION: Our proposed method is an improvement over currently used methods of calculating the clinical NRI and is recommended to reduce overly optimistic results.

Entities:  

Mesh:

Year:  2012        PMID: 23042826      PMCID: PMC3605042          DOI: 10.1177/0272989X12461856

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  20 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 2.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

3.  Evaluating health risk models.

Authors:  Alice S Whittemore
Journal:  Stat Med       Date:  2010-10-15       Impact factor: 2.373

4.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ewout W Steyerberg
Journal:  Stat Med       Date:  2010-11-05       Impact factor: 2.373

5.  The threshold approach to clinical decision making.

Authors:  S G Pauker; J P Kassirer
Journal:  N Engl J Med       Date:  1980-05-15       Impact factor: 91.245

6.  Testing for improvement in prediction model performance.

Authors:  Margaret Sullivan Pepe; Kathleen F Kerr; Gary Longton; Zheyu Wang
Journal:  Stat Med       Date:  2013-01-07       Impact factor: 2.373

7.  Use and misuse of the receiver operating characteristic curve in risk prediction.

Authors:  Nancy R Cook
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

8.  A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Authors:  Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

9.  A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses.

Authors:  Samuli Ripatti; Emmi Tikkanen; Marju Orho-Melander; Aki S Havulinna; Kaisa Silander; Amitabh Sharma; Candace Guiducci; Markus Perola; Antti Jula; Juha Sinisalo; Marja-Liisa Lokki; Markku S Nieminen; Olle Melander; Veikko Salomaa; Leena Peltonen; Sekar Kathiresan
Journal:  Lancet       Date:  2010-10-23       Impact factor: 79.321

10.  Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.

Authors:  Matthew E Mealiffe; Renee P Stokowski; Brian K Rhees; Ross L Prentice; Mary Pettinger; David A Hinds
Journal:  J Natl Cancer Inst       Date:  2010-10-18       Impact factor: 13.506

View more
  20 in total

1.  Application of net reclassification index to non-nested and point-based risk prediction models: a review.

Authors:  Laine E Thomas; Emily C O'Brien; Jonathan P Piccini; Ralph B D'Agostino; Michael J Pencina
Journal:  Eur Heart J       Date:  2019-06-14       Impact factor: 29.983

2.  Net reclassification improvement: a link between statistics and clinical practice.

Authors:  Maarten J G Leening; Nancy R Cook
Journal:  Eur J Epidemiol       Date:  2013-01-05       Impact factor: 8.082

3.  Asymptotic distribution of ∆AUC, NRIs, and IDI based on theory of U-statistics.

Authors:  Olga V Demler; Michael J Pencina; Nancy R Cook; Ralph B D'Agostino
Journal:  Stat Med       Date:  2017-06-19       Impact factor: 2.373

4.  Adding tests to risk based guidelines: evaluating improvements in prediction for an intermediate risk group.

Authors:  Nina P Paynter; Nancy R Cook
Journal:  BMJ       Date:  2016-09-07

5.  Cystatin C versus creatinine in determining risk based on kidney function.

Authors:  Michael G Shlipak; Kunihiro Matsushita; Johan Ärnlöv; Lesley A Inker; Ronit Katz; Kevan R Polkinghorne; Dietrich Rothenbacher; Mark J Sarnak; Brad C Astor; Josef Coresh; Andrew S Levey; Ron T Gansevoort
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

6.  Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS).

Authors:  Jehu S Mathew; Michael C Sachs; Ronit Katz; Kristen K Patton; Susan R Heckbert; Andrew N Hoofnagle; Alvaro Alonso; Michel Chonchol; Rajat Deo; Joachim H Ix; David S Siscovick; Bryan Kestenbaum; Ian H de Boer
Journal:  Circulation       Date:  2014-06-11       Impact factor: 29.690

7.  Breast Arterial Calcification: a Novel Cardiovascular Risk Enhancer Among Postmenopausal Women.

Authors:  Carlos Iribarren; Malini Chandra; Catherine Lee; Gabriela Sanchez; Danny L Sam; Farima Faith Azamian; Hyo-Min Cho; Huanjun Ding; Nathan D Wong; Sabee Molloi
Journal:  Circ Cardiovasc Imaging       Date:  2022-03-15       Impact factor: 7.792

8.  Lipoprotein(a) and Cardiovascular Risk Prediction Among Women.

Authors:  Nancy R Cook; Samia Mora; Paul M Ridker
Journal:  J Am Coll Cardiol       Date:  2018-07-09       Impact factor: 24.094

9.  Cohort Study of ECG Left Ventricular Hypertrophy Trajectories: Ethnic Disparities, Associations With Cardiovascular Outcomes, and Clinical Utility.

Authors:  Carlos Iribarren; Alfred D Round; Meng Lu; Peter M Okin; Edward J McNulty
Journal:  J Am Heart Assoc       Date:  2017-10-05       Impact factor: 5.501

10.  Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events.

Authors:  F G R Fowkes; G D Murray; I Butcher; A R Folsom; A T Hirsch; D J Couper; G Debacker; M Kornitzer; A B Newman; K C Sutton-Tyrrell; M Cushman; A J Lee; J F Price; R B D'Agostino; J M Murabito; Pe Norman; K H Masaki; L M Bouter; R J Heine; C D A Stehouwer; M M McDermott; H E J H Stoffers; J A Knottnerus; M Ogren; B Hedblad; W Koenig; C Meisinger; J A Cauley; Oh Franco; M G M Hunink; A Hofman; J C Witteman; M H Criqui; R D Langer; W R Hiatt; R F Hamman
Journal:  Eur J Prev Cardiol       Date:  2013-12-23       Impact factor: 7.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.